心脏骤停试验中向未存活患者家属告知入组情况的方法系统分析
该研究系统检索试验注册库,纳入2010至2022年间招募成人心脏骤停患者(或自主循环恢复后1小时内)的随机临床试验,共识别710项独特试验,108项符合纳入标准,从64项(62%)试验的研究者处获取信息。约44%(95%CI 31%至57%)的试验尝试主动告知未存活患者家属,39%(95%CI 27%至52%)未做任何尝试,17%(95%CI 8%至29%)向家属提供一般信息但不主动告知。结论认为,心脏骤停随机临床试验中向未存活患者家属告知入组情况的做法存在广泛差异。
要点
- 在64项提供信息的试验中,28项(44%,95%CI 31%至57%)主动告知未存活患者家属其入组情况。
- 25项试验(39%,95%CI 27%至52%)未做任何尝试告知未存活患者家属试验入组情况。
- 11项试验(17%,95%CI 8%至29%)向家属提供试验一般信息但不主动告知入组。
- 全球范围内对心脏骤停试验中未存活患者家属的告知方法存在广泛差异。
适用人群与场景
- 2010至2022年间招募的成人心脏骤停患者(心脏骤停期间或自主循环恢复后1小时内入组)的随机临床试验。
研究设计与关键结果
- 研究类型为系统检索试验注册库的描述性分析,检索识别710项独特试验,108项符合纳入标准,从64项(62%)试验的研究者处获取信息。
- 主动告知未存活患者家属的试验28项(44%,95%CI 31%至57%)。
- 未做任何尝试告知的试验25项(39%,95%CI 27%至52%)。
- 提供一般信息但不主动告知的试验11项(17%,95%CI 8%至29%)。
证据类型、等级与局限
- 证据类型:系统检索试验注册库的描述性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐;原文结论指出心脏骤停随机临床试验中向未存活患者家属告知入组情况的做法存在广泛差异。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The recruitment of patients to emergency research studies without the requirement for prior informed consent has furthered the conduct of randomised studies in cardiac arrest. Frameworks enabling this vary around the world depending on local legal or ethical requirements. When an enrolled patient does not survive, researchers may take one of three approaches to inform relatives of their enrolment: a direct (active) approach, providing information indirectly (passively) and inviting relatives to seek further information if they choose, or providing no information about the trial (no attempt). Previous studies have described experiences of US researchers' active approach but there is little known about approaches elsewhere.We aimed to conduct a structured investigation of methods used in cardiac arrest trials to provide information about trial enrolment to relatives of non-surviving patients.
METHODS: We systematically searched trial registries to identify randomised clinical trials that recruited cardiac arrest patients. Trials were eligible for inclusion if they recruited adults during cardiac arrest (or within 1 hour of return of spontaneous circulation) between 2010 and 2022 (in the decade prior to study conception). We extracted data from trial registries and, where relevant, published papers and protocols. Investigators were contacted and asked to describe the style, rationale and timing of approach to relatives of non-surviving patients. We present descriptive statistics.
RESULTS: Our trial registry search identified 710 unique trials, of which 108 were eligible for inclusion. We obtained information from investigators for 64 (62%) trials. Approximately equal numbers of trials attempted to actively inform relatives of non-survivors (n=28 (44% (95% CI; 31% to 57%))), or made no attempt (n=25 (39% (95% CI; 27% to 52%))). The remaining studies provided general information about the trial to relatives but did not actively inform them (n=11 (17% (95% CI; 8% to 29%))).
CONCLUSIONS: There is wide variability in the approach taken to informing relatives of non-surviving patients enrolled in cardiac arrest randomised clinical trials.
参考来源
- Pocock H, Dove A, Pointeer L, et al. Systematic analysis of approaches used in cardiac arrest trials to inform relatives about trial enrolment of non-surviving patients. Emerg Med J. 2025. PMID: 38729750. doi:10.1136/emermed-2023-213648
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。